NIH Starting H1N1 Vaccine Trial in Pregnant Women with HIV
The National Institutes of Health (NIH) are funding a clinical trial of the H1N1 vaccine in pregnant women with HIV to determine its effectiveness in women with weakend immune systems from the HIV virus. The trial will involve a higher than normal dose of the vaccine to see if it results in an immunity in these women.
Click to read the press release
Click to read the press release
